Genie Therapeutics, founded in 2007 by Dr. Tabor, focuses on developing advanced gene therapy technologies aimed at skin restoration and rejuvenation. The company's core mission is to utilize patented, third-generation non-viral gene transfer methods to heal, restore, and regenerate skin, thereby improving the quality of life for countless patients. Genie's Therapeutics offers innovative therapeutic solutions designed to rejuvenate and transform skin, with a primary market focus on individuals seeking advanced dermatological treatments.
Notable affiliated individuals include Dr. Tabor, whose expertise and vision drive the company's pioneering efforts in gene therapy. Genie Therapeutics has achieved significant milestones in the field of dermatological gene therapy, securing patents for its unique non-viral delivery systems. The company's impact is evident in its ability to provide cutting-edge treatments that address various skin conditions, positioning it as a leader in the biotechnology sector focused on skin health and regeneration.
Genie's Therapeutics' most recent funding round was for $50k (USD) in July 2023.
As of Jul 27, 2023, Genie's Therapeutics has disclosed funding of $50k (USD).

Intergalactic Therapeutics

Dermaliq Therapeutics
dermaliq.com

Genascence
genascence.com

Histogen
histogen.com

PMGC Holdings

Stemgenics
stemgenics.com

Gensaic
gensaic.com
Genecure
genecure.com

Rejuvenate Bio
rejuvenatebio.com

GenieBiome
geniebiome.com
Geneius
geneius.com

Jaguar Gene Therapy

GeniPhys
geniphys.com

Theragene Pharmaceuticals

RegenX Science
regenxscience.com

Exegenesis Bio
exegenesisbio.com

Endogena Therapeutics
endogena.com

Angiocrine Bioscience
angiocrinebio.com

Repairogen
repairogen.com

Oculogenex
oculogenex.com